LEXICON PHARMACEUTICALS, INC. financial data

Symbol
LXRX on Nasdaq
Location
The Woodlands, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 357% % -62%
Quick Ratio 0.36% % -80%
Debt-to-equity 98% % 45%
Return On Equity -53% % 51%
Return On Assets -27% % 59%
Operating Margin -94% % 98%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 363,398,680 shares 0.53%
Common Stock, Shares, Outstanding 365,780,799 shares
Entity Public Float $297,100,000 USD 8.6%
Common Stock, Value, Issued $366,000 USD 0.83%
Weighted Average Number of Shares Outstanding, Basic 363,399,000 shares 0.53%
Weighted Average Number of Shares Outstanding, Diluted 363,399,000 shares 0.53%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $70,864,000 USD 1255%
Revenue from Contract with Customer, Excluding Assessed Tax $6,170,000 USD 180%
Research and Development Expense $76,492,000 USD 5.4%
Costs and Expenses $137,731,000 USD -36%
Operating Income (Loss) $66,867,000 USD 68%
Net Income (Loss) Attributable to Parent $68,578,000 USD 68%
Earnings Per Share, Basic 0 USD/shares 76%
Earnings Per Share, Diluted 0 USD/shares 76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $49,656,000 USD 44%
Accounts Receivable, after Allowance for Credit Loss, Current $2,334,000 USD -19%
Inventory, Net $158,000 USD -75%
Other Assets, Current $4,085,000 USD -39%
Assets, Current $122,527,000 USD -54%
Property, Plant and Equipment, Net $1,981,000 USD -7.2%
Operating Lease, Right-of-Use Asset $7,508,000 USD 50%
Goodwill $44,543,000 USD 0%
Other Assets, Noncurrent $368,000 USD -56%
Assets $205,927,000 USD -36%
Accounts Payable, Current $3,797,000 USD -73%
Employee-related Liabilities, Current $4,787,000 USD -57%
Accrued Liabilities, Current $13,620,000 USD -38%
Contract with Customer, Liability, Current $4,303,000 USD
Liabilities, Current $21,720,000 USD -40%
Operating Lease, Liability, Noncurrent $6,795,000 USD 45%
Other Liabilities, Noncurrent $7,540,000 USD 13%
Liabilities $85,768,000 USD -40%
Accumulated Other Comprehensive Income (Loss), Net of Tax $29,000 USD -92%
Retained Earnings (Accumulated Deficit) $2,002,054,000 USD -3.5%
Stockholders' Equity Attributable to Parent $120,159,000 USD -33%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $120,159,000 USD -33%
Liabilities and Equity $205,927,000 USD -36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $43,778,000 USD 21%
Net Cash Provided by (Used in) Financing Activities $572,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $40,582,000 USD
Common Stock, Shares Authorized 450,000,000 shares 0%
Common Stock, Shares, Issued 365,780,799 shares 0.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,768,000 USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78,656,000 USD 128%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,968,000 USD -8.9%
Deferred Tax Assets, Valuation Allowance $420,933,000 USD 7.9%
Deferred Tax Assets, Gross $422,290,000 USD 7.8%
Operating Lease, Liability $8,437,000 USD 41%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $68,898,000 USD 68%
Lessee, Operating Lease, Liability, to be Paid $12,069,000 USD 35%
Property, Plant and Equipment, Gross $4,570,000 USD 12%
Operating Lease, Liability, Current $1,642,000 USD 26%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,649,000 USD 35%
Lessee, Operating Lease, Liability, to be Paid, Year One $424,000 USD 23%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 Rate 10%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,632,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,683,000 USD 95%
Deferred Tax Assets, Operating Loss Carryforwards $316,034,000 USD 9.6%
Preferred Stock, Shares Issued 2,304,147 shares 0%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,718,000 USD 95%
Additional Paid in Capital $2,127,005,000 USD 0.52%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $176,000 USD 22%
Share-based Payment Arrangement, Expense $11,100,000 USD -27%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%